BackgroundCheck.run
Search For

Harold J Jensen Deceased333 2Nd St, South Minden, NE 68959

Harold Jensen Phones & Addresses

333 2Nd St, Minden, NE 68959    308-8322587   

Anchorage, AK   

Hollister, MO   

La Mirada, CA   

Lincoln, NE   

10637 Washington Cir, Anchorage, AK 99515    907-3507703   

Emails

Mentions for Harold J Jensen

Career records & work history

Medicine Doctors

Harold Jensen Photo 1

Harold Leroy Jensen

Specialties:
Internal Medicine
Education:
University of Illinois at Chicago (1955)

Harold Jensen resumes & CV records

Resumes

Harold Jensen Photo 42

Global Clinical Project Manager At Allergan

Position:
Global Clinical Project Manager at Allergan
Location:
United States
Work:
Allergan since Feb 1993
Global Clinical Project Manager
Allergan 1992 - 2011
Global Clinical Project Manager
Allergan 1992 - 2010
Clinical Project manager
Education:
University of Oklahoma Health Sciences Center 1975 - 1982
Ph.D., Virology, Microbiology
Emporia State University 1972 - 1973
MS, Virology
Kansas State University 1963 - 1968
BS, Microbiology
Kinsley High School
Harold Jensen Photo 43

Harold Jensen

Location:
United States

Publications & IP owners

Us Patents

Antibiotic Compositions And Methods For Using Same

US Patent:
6492361, Dec 10, 2002
Filed:
Oct 5, 2000
Appl. No.:
09/680810
Inventors:
Christopher A. Muller - Foothill Ranch CA
Elizabeth A. Bancroft - Irvine CA
Janet K. Cheetham - Laguna Niguel CA
Harold G. Jensen - Lake Forest CA
Teresa H. Kuan - Placentia CA
David F. Power - Trabuco Canyon CA
Kevin D. Skule - Rancho Santa Margarita CA
Assignee:
Allergan Sales, Inc - Irvine CA
International Classification:
A62K 3902
US Classification:
5142355, 514250, 514254, 514912
Abstract:
Compositions including a quinolone component in an amount effective as an antibiotic when the composition is placed in a mammalian eye, and a carrier component in an amount effective to act as a carrier for the quinolone component are provided. The present compositions are substantially free of other components effective as preservatives. Preferably the quinolone component has fungistatic activity. In one very useful embodiment, the compositions include a NSAID component in an amount effective to reduce inflammation or pain when the composition is placed in a mammalian eye. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention.

Methods Of Reducing Non-Inflammatory Pain

US Patent:
6548497, Apr 15, 2003
Filed:
Apr 19, 2001
Appl. No.:
09/838772
Inventors:
Janet K. Cheetham - Laguna Niguel CA
Harold G. Jensen - Lake Forest CA
Christopher A. Muller - Foothill Ranch CA
David F. Power - Trabuco Canyon CA
Kevin D. Skule - Rancho Santa Margarita CA
Assignee:
Allergan Sales, Inc. - Irvine CA
International Classification:
A61K 31535
US Classification:
5142355, 514912
Abstract:
Methods for reducing non-inflammatory pain caused by injuries and traumas include administering to a mammal eye having non-inflammatory pain a therapeutically effective amount of a composition comprising a quinolone component in an amount effective as an antibiotic and a NSAID component in an amount effective, in combination with the quinolone component, to provide a reduction in non-inflammatory pain.

Compositions Including Antibiotics And Methods For Using Same

US Patent:
6552020, Apr 22, 2003
Filed:
Jul 24, 2000
Appl. No.:
09/624129
Inventors:
Christopher A. Muller - Foothill Ranch CA
Elizabeth A. Bancroft - Irvine CA
Janet K. Cheetham - Laguna Niguel CA
Harold G. Jensen - Lake Forest CA
Teresa H. Kuan - Placentia CA
David F. Power - Trabuco Canyon CA
Kevin D. Skule - Rancho Santa Margarita CA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31535
US Classification:
5142355, 514250, 514912
Abstract:
Compositions including a quinolone component, such as ofloxacin, having fungistatic activity in the compositions, present in an amount effective as an antibiotic when the composition is placed in a mammalian eye, a NSAID component present in an amount to reduce inflammation or pain when the composition is placed in the eye, and a carrier component in an amount effective to act as a carrier for the quinolone component and NSAID component are provided. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention. Methods for treating corneal injuries are also included. In addition, methods for treating ocular infections, for example, corneal infections, are included.

Antibiotic Compositions And Methods For Using Same

US Patent:
2003007, Apr 17, 2003
Filed:
Jul 12, 2002
Appl. No.:
10/194834
Inventors:
Christopher Muller - Foothill Ranch CA, US
Elizabeth Bancroft - Irvine CA, US
Janet Cheetham - Loguna Niguel CA, US
Harold Jensen - Lake Forest CA, US
Teresa Kuan - Placentia CA, US
David Power - Trabuco Canyon CA, US
Kevin Skule - Rancho Santa Margarita CA, US
Assignee:
Allergan Sales, Inc. - Irvine CA
International Classification:
A61K031/496
A61K031/4709
A61K031/47
A61K031/415
A61K031/192
US Classification:
514/253080, 514/312000, 514/161000, 514/406000, 514/569000
Abstract:
Compositions including a quinolone component in an amount effective as an antibiotic when the composition is placed in a mammalian eye, and a carrier component in an amount effective to act as a carrier for the quinolone component are provided. The present compositions are substantially free of other components effective as preservatives. Preferably the quinolone component has fungistatic activity. In one very useful embodiment, the compositions include a NSAID component in an amount effective to reduce inflammation or pain when the composition is placed in a mammalian eye. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention.

Compositions Including Antibiotics And Methods For Using Same

US Patent:
2003011, Jun 19, 2003
Filed:
Sep 6, 2002
Appl. No.:
10/236712
Inventors:
Christopher Muller - Foothill Ranch CA, US
Elizabeth Bancroft - Irvine CA, US
Janet Cheetham - Laguna Niguel CA, US
Harold Jensen - Lake Forest CA, US
Teresa Kuan - Placentia CA, US
David Power - Trabuco Canyon CA, US
Kevin Skule - Rancho Santa Margarita CA, US
Assignee:
Allergan Sales, Inc. - Irvine CA
International Classification:
A61K031/496
A61K031/47
A61K031/192
US Classification:
514/253080, 514/312000, 514/570000
Abstract:
Compositions including a quinolone component, such as ofloxacin, having fungistatic activity in the compositions, present in an amount effective as an antibiotic when the composition is placed in a mammalian eye, a NSAID component present in an amount to reduce inflammation or pain when the composition is placed in the eye, and a carrier component in an amount effective to act as a carrier for the quinolone component and NSAID component are provided. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention. Methods for treating corneal injuries are also included. In addition, methods for treating ocular infections, for example, corneal infections, are included.

Compositions Including Antibiotics And Methods For Using Same

US Patent:
2008007, Mar 20, 2008
Filed:
Sep 13, 2007
Appl. No.:
11/900942
Inventors:
Christopher Muller - Foothill Ranch CA, US
Elizabeth Bancroft - Irvine CA, US
Janet Cheetham - Laguna Niguel CA, US
Harold Jensen - Lake Forest CA, US
Teresa Kuan - Placentia CA, US
David Power - Trabuco Canyon CA, US
Kevin Skule - Rancho Santa Margarita CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31/196
A61K 31/5365
A61P 27/02
A61P 29/00
US Classification:
514230200, 514567000
Abstract:
Compositions including a quinolone component, such as ofloxacin, having fungistatic activity in the compositions, present in an amount effective as an antibiotic when the composition is placed in a mammalian eye, a NSAID component present in an amount to reduce inflammation or pain when the composition is placed in the eye, and a carrier component in an amount effective to act as a carrier for the quinolone component and NSAID component are provided. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention. Methods for treating corneal injuries are also included. In addition, methods for treating ocular infections, for example, corneal infections, are included.

Antibiotic Compostions And Methods For Using Same

US Patent:
2008014, Jun 19, 2008
Filed:
Feb 20, 2008
Appl. No.:
12/070854
Inventors:
Christopher A. Muller - Foothill Ranch CA, US
Elizabeth A. Bancroft - Irvine CA, US
Janet K. Cheetham - Laguna Niguel CA, US
Harold G. Jensen - Lake Forest CA, US
Teresa H. Kuan - Placentia CA, US
David F. Power - Trabuco Canyon CA, US
Kevin D. Skule - Rancho Santa Margarita CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31/5365
A61K 31/47
A61P 27/00
A61P 31/00
US Classification:
5142302, 514311
Abstract:
Compositions including a quinolone component in an amount effective as an antibiotic when the composition is placed in a mammalian eye, and a carrier component in an amount effective to act as a carrier for the quinolone component are provided. The present compositions are substantially free of other components effective as preservatives. Preferably the quinolone component has fungistatic activity. In one very useful embodiment, the compositions include a NSAID component in an amount effective to reduce inflammation or pain when the composition is placed in a mammalian eye. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention.

Ophthalmic Compositions Comprising Ddc

US Patent:
2010005, Mar 4, 2010
Filed:
Mar 21, 2006
Appl. No.:
11/909479
Inventors:
Patrick M. Hughes - Aliso Viejo CA, US
Rhett M. Schiffman - Laguna Beach CA, US
Harold G. Jensen - Lake Forest CA, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 31/495
A61P 27/02
US Classification:
514256
Abstract:
A composition comprising dDC and a polymer, wherein the composition is an aqueous liquid with a viscosity which increases upon contact with a surface of an eye is disclosed herein.An aqueous composition comprising a therapeutically effective concentration of dDC, wherein the concentration of dDC is less than 1% is also disclosed.An eye drop comprising a therapeutically effective amount of dDC, wherein the amount of dDC is less than 300 μg is also disclosed.A method comprising administering an effective amount of dDC topically to an eye of a person suffering from viral conjunctivitis a viral infection, wherein less than 300 μL of dDC is administered to said eye is also disclosed.A kit comprising a composition and a dispenser, wherein said dispenser dispenses a drop comprising a therapeutically effective amount of dDC, wherein the amount of dDC is less than 300 μg is also disclosed.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.